Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis

Clinics and Research in Hepatology and Gastroenterology

Volumn 40, Issue 1, 2016, Pages 110-123

  Luo, Su ^a   Li, Jie Yao ^a   Zhao, Li Na ^b   Yu, Tao ^a   Zhong, Wa ^a   Xia, Zhong Sheng ^a   Shan, Ti Dong ^a   Ouyang, Hui ^a   Yang, Hong Sheng ^a   Chen, Qi Kui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; COLORECTAL ADENOMA; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE ASSOCIATION; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; DIABETES COMPLICATIONS; META ANALYSIS; RISK FACTOR;

COLORECTAL NEOPLASMS; DIABETES COMPLICATIONS; HUMANS; RISK FACTORS;

EID: 84959527840     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.05.021     Document Type: Article

References (61)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Boyle P., Anderson B.O., Andersson L.C., Ariyaratne Y., Auleley G.R., Bartelink H., et al. Need for global action for cancer control. Ann Oncol 2008, 19:1519-1521.
3. Giovannucci E., Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007, 132:2208-2225.
4. Potter J.D. Nutrition and colorectal cancer. Cancer Causes Control 1996, 7:127-146.
5. Willett W. The search for the causes of breast and colon cancer. Nature 1989, 338:389-394.
6. Giovannucci E., Ascherio A., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995, 122:327-334.
7. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?. Cancer Epidemiol Biomarkers Prev 1994, 3:687-695.
8. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995, 6:164-179.
9. Berster J.M., Goke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 2008, 114:84-98.
10. Smith C.J., McKay G.A., Fisher M. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition. Int J Clin Pract 2008, 62:810-815.
11. Li J.Y., Yu T., Xia Z.S., Chen G.C., Yuan Y.H., Zhong W., et al. Enhanced proliferation in colorectal epithelium of patients with type 2 diabetes correlates with beta-catenin accumulation. J Diabetes Complications 2014, 28:689-697.
12. Larsson S.C., Orsini N., Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005, 97:1679-1687.
13. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
14. Wells G.A., Shea B., Connell D.O., Peterson J., Welch V., Losos M., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2014, [Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp].
15. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987, 9:1-30.
16. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
17. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
18. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
19. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
20. Egger M., Davey S.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
21. Ogunleye A.A., Ogston S.A., Morris A.D., Evans J.M. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009, 101:1199-1201.
22. Kao C.H., Sun L.M., Chen P.C., Lin M.C., Liang J.A., Muo C.H., et al. A population-based cohort study in Taiwan--use of insulin sensitizers can decrease cancer risk in diabetic patients?. Ann Oncol 2013, 24:523-530.
23. Yeh H.C., Platz E.A., Wang N.Y., Visvanathan K., Helzlsouer K.J., Brancati F.L. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 2012, 35:113-118.
24. La Vecchia C., Negri E., Decarli A., Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997, 6:1007-1010.
25. Kono S., Honjo S., Todoroki I., Nishiwaki M., Hamada H., Nishikawa H., et al. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 1998, 9:441-446.
26. Will J.C., Galuska D.A., Vinicor F., Calle E.E. Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol 1998, 147:816-825.
27. Hu F.B., Manson J.E., Liu S., Hunter D., Colditz G.A., Michels K.B., et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999, 91:542-547.
28. Schoen R.E., Tangen C.M., Kuller L.H., Burke G.L., Cushman M., Tracy R.P., et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999, 91:1147-1154.
29. Marugame T., Lee K., Eguchi H., Oda T., Shinchi K., Kono S. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control 2002, 13:917-921.
30. Limburg P.J., Anderson K.E., Johnson T.W., Jacobs D.R., Lazovich D., Hong C.P., et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005, 14:133-137.
31. Seow A., Yuan J.M., Koh W.P., Lee H.P., Yu M.C. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006, 98:135-138.
32. Rapp K., Schroeder J., Klenk J., Ulmer H., Concin H., Diem G., et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006, 49:945-952.
33. Inoue M., Iwasaki M., Otani T., Sasazuki S., Noda M., Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006, 166:1871-1877.
34. Rousseau M.C., Parent M.E., Pollak M.N., Siemiatycki J. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 2006, 118:2105-2109.
35. Hu S.Q., Tang Z., Zhang M. Investigation on the risks of colorectal cancer in patients with diabetes mellitus. Shi Jie Hua Ren Xiao Hua Za Zhi 2007, 15:88-91. [Article in Chinese].
36. He J., Stram D.O., Kolonel L.N., Henderson B.E., Le M.L., Haiman C.A. The association of diabetes with colorectal cancer risk: the multiethnic cohort. Br J Cancer 2010, 103:120-126.
37. Flood A., Strayer L., Schairer C., Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 2010, 21:1277-1284.
38. Pelucchi C., Negri E., Talamini R., Levi F., Giacosa A., Crispo A. Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer 2010, 46:1866-1872.
39. Kang H.W., Kim D., Kim H.J., Kim C.H., Kim Y.S., Park M.J. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol 2010, 105:178-187.
40. Cheng I., Caberto C.P., Lum-Jones A., Seifried A., Wilkens L.R., Schumacher F.R. Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies. Gut 2011, 60:1703-1711.
41. Li L., Huang H.L., Zhang X.Y., Zhang X.Y., Lv Z.H. Association of metabolic syndrome and colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2011, 14:948-951. [Article in Chinese].
42. Kramer H.U., Muller H., Stegmaier C., Rothenbacher D., Raum E., Brenner H. Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia. Eur J Epidemiol 2012, 27:341-347.
43. Fang Y., Zhou H., Ni H.Z., Ye L.C., Huang H. Type 2 diabetes and risk of colorectal adenoma. Zhong Guo Yi Kan 2012, 47:54-56. [Article in Chinese].
44. Acevedo A., Diaz Y., Perez C.M., Garau M., Baron J., Cruz-Correa M. Diabetes mellitus and colorectal neoplasia. J Cancer Ther 2012, 3:859-865.
45. Cavicchia P.P., Adams S.A., Steck S.E., Hussey J.R., Liu J., Daguise V.G., et al. Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status. Cancer Causes Control 2013, 24:277-285.
46. Chiu C.C., Huang C.C., Chen Y.C., Chen T.J., Liang Y., Lin S.J., et al. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan. Intern Med 2013, 52:939-946.
47. Luo J., Chlebowski R., Liu S., McGlynn K.A., Parekh N., White D.L., et al. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 2013, 24:577-585.
48. Vu H.T., Ufere N., Yan Y., Wang J.S., Early D.S., Elwing J.E. Diabetes mellitus increases risk for colorectal adenomas in younger patients. World J Gastroenterol 2014, 20:6946-6952.
49. Jarvandi S., Davidson N.O., Schootman M. Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality. Plos One 2013, 8:e74616.
50. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001, 131:3109S-3120S.
51. Airley R.E., Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007, 53:233-256.
52. Stadler J., Yeung K.S., Furrer R., Marcon N., Himal H.S., Bruce W.R. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett 1988, 38:315-320.
53. Kramer H.U., Schottker B., Raum E., Hermann B. Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences. Eur J Cancer 2012, 48:1269-1282.
54. Deng L.Y., Gui Z.F., Zhao L.Y., Wang J.P., Shen L.Z. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012, 57:1576-1585.
55. Wu L., Yu C., Jiang H., Tang J., Huang H.L., Gao J., et al. Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies. Diabetes Technol Ther 2013, 15:419-427.
56. Sun L., Yu S.Y. Diabetes mellitus is an independent risk factor for colorectal cancer. Dig Dis Sci 2012, 57:1586-1597.
57. Huxley R.R., Ansary-Moghaddam A., Clifton P., Czernichow S., Parr C.L., Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009, 125:171-180.
58. Szmuilowicz E.D., Stuenkel C.A., Seely E.W. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 2009, 5:553-558.
59. Yamamoto S., Nakagawa T., Matsushita Y., Kusano S., Hayashi T., Irokawa M., et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care 2010, 33:184-189.
60. Franciosi M., Lucisano G., Lapice E., Strippoli G.F., Pellegrini F., Nicolucci A. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. Plos One 2013, 8:e71583.
61. Janghorbani M., Dehghani M., Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Horm Cancer 2012, 3:137-146.